MURALI  CHINTAGUMPALA  to  Antineoplastic Agents, Alkylating
                            
                            
                                This is a "connection" page, showing publications  MURALI  CHINTAGUMPALA  has written about  Antineoplastic Agents, Alkylating.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.314
         
        
        
     
 
    
        
        - 
            A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study?. Neuro Oncol. 2015 Aug; 17(8):1132-8.
            
            
                Score: 0.113
             
- 
            Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol. 2006 Feb; 76(3):313-9.
            
            
                Score: 0.060
             
- 
            Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer. 2005 Jan 01; 103(1):133-9.
            
            
                Score: 0.055
             
- 
            Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
            
            
                Score: 0.042
             
- 
            Pulmonary Function After Treatment for Embryonal Brain Tumors on SJMB03 That Included Craniospinal Irradiation. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):47-53.
            
            
                Score: 0.028
             
- 
            Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006 Oct; 7(10):813-20.
            
            
                Score: 0.016